Article Details
Retrieved on: 2022-11-28 21:29:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
C4X entered into a licensing deal with AstraZeneca to develop an oral treatment for COPD and other inflammatory and respiratory illnesses that ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here